Lifeway Foods (LWAY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Achieved record quarterly net sales of $66.9 million in Q2 2026, up 24.1% year-over-year, surpassing the previous record by $3.9 million, and marking 27 consecutive quarters of year-over-year net sales growth.
First half 2026 net sales totaled $129.9 million, up 29.9% year-over-year, representing 61% of full year 2025 net sales.
Growth driven by higher volumes of flagship Lifeway Kefir and Farmer Cheese, supported by strong consumer trends in protein and digestive health.
Celebrated 40th anniversary with nationwide marketing campaigns, pop-up events, and digital activations, increasing consumer engagement and brand visibility.
Expanded distribution and product innovation, including new placements for Muscle Mates, Farmer Cheese, and Kefir Butter across major retailers.
Financial highlights
Q2 2026 net sales: $66.9 million (+24.1% YoY); H1 2026 net sales: $129.9 million (+29.9% YoY).
Q2 2026 gross margin: 19.5% (down from 28.6% YoY) due to elevated milk, resin, and packaging costs.
Q2 2026 net income: $127,000 ($0.01 per share), down from $4.2 million in Q2 2025; H1 2026 net income: $4.8 million.
SG&A: 18.4% of net sales in Q2 2026; year-to-date SG&A down to 17.8% of net sales.
Cash and cash equivalents at June 30, 2026: $7.1 million; total assets: $132.4 million.
Outlook and guidance
Elevated input costs, especially milk and resin-based packaging, expected to remain a headwind in Q3 2026, with relief anticipated in Q4 and full recovery in 2027 as pricing actions and operational improvements take effect.
Focused on disciplined execution, balancing growth investments with profitability, and leveraging brand momentum for sustained growth.
Waukesha facility expansion on track for early 2027 completion, expected to double capacity and improve efficiency.
Latest events from Lifeway Foods
- All proposals passed, with strong growth, innovation, and expanded distribution highlighted.LWAY
AGM 2026 - Shareholders will vote on eight board nominees, including Jason Scher, and key annual proposals.LWAY
Proxy filing - Record $63M sales and 32% net income growth, driven by kefir, innovation, and margin gains.LWAY
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, highlighting governance and ESG.LWAY
Proxy filing - Votes will be cast on board elections, auditor ratification, and executive pay at the 2026 meeting.LWAY
Proxy filing - Record sales and profit growth, margin expansion, and innovation drive strong 2026 outlook.LWAY
Q4 2025 - ISS backs the full board slate for the 2025 meeting, urging shareholders to vote accordingly.LWAY
Proxy Filing - Q3 2024 sales up 12.7%, net income $3M, global expansion, and Danone bid rejected.LWAY
Q3 2024 - Q2 net sales rose 25.3% to $49.2M, net income hit $3.8M, and all debt was repaid.LWAY
Q2 2024